Idiopathic intracranial hypertension (IIH)
Idiopathic intracranial hypertension (also known as pseudotumour cerebri and formerly benign intracranial hypertension) is a condition classically seen in young, overweight females.
Risk factors
- obesity
- female sex
- pregnancy
- drugs
- combined oral contraceptive pill
- steroids
- tetracyclines
- retinoids (isotretinoin, tretinoin) / vitamin A
- lithium
Features
- headache
- blurred vision
- papilloedema (usually present)
- enlarged blind spot
- sixth nerve palsy may be present
Management
- weight loss
- whilst diet and exercise are important, medications such as semaglitide and topiramate may be considered by specialists. Topiramate is particularly beneficial as it also inhibits carbonic anhydrase
- carbonic anhydrase inhibitors e.g. acetazolamide
- topiramate is also used, and has the added benefit of causing weight loss in most patients
- repeated lumbar puncture may be used as a temporary measure but is not suitable for longer-term management
- surgery: optic nerve sheath decompression and fenestration may be needed to prevent damage to the optic nerve. A lumboperitoneal or ventriculoperitoneal shunt may also be performed to reduce intracranial pressure